Catalyst Wire Dossier Catalyst Wire Dossier

Daunorubicin hydrochloride

daunorubicin hydrochloride
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Daunorubicin hydrochloride, covering 2013-06-05 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]

See pricing